FDA Experts Find No Misconduct in Avandia Tests

FDA Experts Find No Misconduct in Avandia Tests

A review of a disputed clinical trial that minimized the safety issues involving the diabetes drug Avandia did not uncover serious misconduct or fraud, according to findings by experts at the Food and Drug Administration that were made public Monday.

10
Like
Save

Comments

Write a comment

*